Pirfenidone?is used for the treatment of idiopathic pulmonary fibrosis (scarring of the lungs with an unknown cause).
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Pirfenidone industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Tablet
Capsule
Other
Market Segment by Product Application
Mild Idiopathic Pulmonary Fibrosis
Moderate Idiopathic Pulmonary Fibrosis
Other
Finally, the report provides detailed profile and data information analysis of leading company.
Genentech (Roche)
Shionogi
GNI Group
Beijing Continent
Cipla
Lupin Ltd
Zydus Cadila
Glenmark Pharmaceuticals
Koye Pharmaceuticals
MSN Laboratories
Wockhardt
Incepta Pharmaceuticals
Unimed Unihealth
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Pirfenidone consumption (value) by key regions/countries, product type and application, history data from 2016 to 2020, and forecast to 2026.
2.To understand the structure of Pirfenidone market by identifying its various subsegments.
3.Focuses on the key global Pirfenidone manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Pirfenidone with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Pirfenidone submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Pirfenidone Market Research Report 2021, Forecast to 2026
1 Market Study Overview
1.1 Study Objectives
1.2 Pirfenidone Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Pirfenidone Segment by Type
2.1.1 Tablet
2.1.2 Capsule
2.1.3 Other
2.2 Market Analysis by Application
2.2.1 Mild Idiopathic Pulmonary Fibrosis
2.2.2 Moderate Idiopathic Pulmonary Fibrosis
2.2.3 Other
2.3 Global Pirfenidone Market Comparison by Regions (2016-2026)
2.3.1 Global Pirfenidone Market Size (2016-2026)
2.3.2 North America Pirfenidone Status and Prospect (2016-2026)
2.3.3 Europe Pirfenidone Status and Prospect (2016-2026)
2.3.4 China Pirfenidone Status and Prospect (2016-2026)
2.3.5 Japan Pirfenidone Status and Prospect (2016-2026)
2.3.6 Southeast Asia Pirfenidone Status and Prospect (2016-2026)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Pirfenidone Industry Impact
2.5.1 Pirfenidone Business Impact Assessment - Covid-19
2.5.2 Market Trends and Pirfenidone Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Pirfenidone Sales and Market Share by Manufacturer (2016-2021)
3.2 Global Pirfenidone Revenue and Market Share by Manufacturer (2016-2021)
3.3 Global Pirfenidone Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Pirfenidone Manufacturer Market Share
3.5 Top 10 Pirfenidone Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Pirfenidone Market
3.7 Key Manufacturers Pirfenidone Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Pirfenidone Industry Key Manufacturers
4.1 Genentech (Roche)
4.1.1 Compan Detail
4.1.2 Genentech (Roche) Pirfenidone Product Introduction, Application and Specification
4.1.3 Genentech (Roche) 160 Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.1.4 Main Business Overview
4.1.5 Genentech (Roche) News
4.2 Shionogi
4.2.1 Compan Detail
4.2.2 Shionogi Pirfenidone Product Introduction, Application and Specification
4.2.3 Shionogi Pirfenidone Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.2.4 Main Business Overview
4.2.5 Genentech (Roche) News
4.3 GNI Group
4.3.1 Compan Detail
4.3.2 GNI Group Pirfenidone Product Introduction, Application and Specification
4.3.3 GNI Group Pirfenidone Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.3.4 Main Business Overview
4.3.5 GNI Group News
4.4 Beijing Continent
4.4.1 Compan Detail
4.4.2 Beijing Continent Pirfenidone Product Introduction, Application and Specification
4.4.3 Beijing Continent Pirfenidone Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.4.4 Main Business Overview
4.4.5 Beijing Continent News
4.5 Cipla
4.5.1 Compan Detail
4.5.2 Beijing Continent Pirfenidone Product Introduction, Application and Specification
4.5.3 Cipla Pirfenidone Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.5.4 Main Business Overview
4.5.5 Cipla News
4.6 Lupin Ltd
4.6.1 Compan Detail
4.6.2 Lupin Ltd Pirfenidone Product Introduction, Application and Specification
4.6.3 Lupin Ltd Pirfenidone Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.6.4 Main Business Overview
4.6.5 Lupin Ltd News
4.7 Zydus Cadila
4.7.1 Compan Detail
4.7.2 Zydus Cadila Pirfenidone Product Introduction, Application and Specification
4.7.3 Zydus Cadila Pirfenidone Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Glenmark Pharmaceuticals
4.8.1 Compan Detail
4.8.2 Glenmark Pharmaceuticals Pirfenidone Product Introduction, Application and Specification
4.8.3 Glenmark Pharmaceuticals Pirfenidone Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.8.4 Main Business Overview
4.8.5 Glenmark Pharmaceuticals News
4.9 Koye Pharmaceuticals
4.9.1 Compan Detail
4.9.2 Koye Pharmaceuticals Pirfenidone Product Introduction, Application and Specification
4.9.3 Koye Pharmaceuticals Pirfenidone Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.9.4 Main Business Overview
4.9.5 Koye Pharmaceuticals News
4.10 MSN Laboratories
4.10.1 Compan Detail
4.10.2 MSN Laboratories Pirfenidone Product Introduction, Application and Specification
4.10.3 MSN Laboratories Pirfenidone Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.10.4 Main Business Overview
4.10.5 MSN Laboratories News
4.11 Wockhardt
4.11.1 Compan Detail
4.11.2 Wockhardt Pirfenidone Product Introduction, Application and Specification
4.11.3 Wockhardt Pirfenidone Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.11.4 Main Business Overview
4.11.5 Wockhardt News
4.12 Incepta Pharmaceuticals
4.12.1 Compan Detail
4.12.2 Incepta Pharmaceuticals Pirfenidone Product Introduction, Application and Specification
4.12.3 Incepta Pharmaceuticals Pirfenidone Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.12.4 Main Business Overview
4.12.5 Incepta Pharmaceuticals News
4.13 Unimed Unihealth
4.13.1 Company Details
4.13.2 Unimed Unihealth Pirfenidone Product Introduction, Application and Specification
4.13.3 Unimed Unihealth Pirfenidone Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.13.4 Main Business Overview
4.13.5 Unimed Unihealth News
5 Global Pirfenidone Market Segment by Big Type
5.1 Global Pirfenidone Revenue, Sales and Market Share by Big Type (2016-2021)
5.1.1 Global Pirfenidone Sales and Market Share by Big Type (2016-2021)
5.1.2 Global Pirfenidone Revenue and Market Share by Big Type (2016-2021)
5.2 Tablet Sales Growth Rate and Price
5.2.1 Global Tablet Sales Growth Rate (2016-2021)
5.2.2 Global Tablet Price (2016-2021)
5.3 Capsule Sales Growth Rate and Price
5.3.1 Global Capsule Sales Growth Rate (2016-2021)
5.3.2 Global Capsule Price (2016-2021)
5.4 Other Sales Growth Rate and Price
5.4.1 Global Other Sales Growth Rate (2016-2021)
5.4.2 Global Other Price (2016-2021)
6 Global Pirfenidone Market Segment by Big Application
6.1 Global Pirfenidone Sales Market Share by Big Application (2016-2021)
6.2 Mild Idiopathic Pulmonary Fibrosis Sales Growth Rate (2016-2021)
6.3 Moderate Idiopathic Pulmonary Fibrosis Sales Growth Rate (2016-2021)
6.4 Other Sales Growth Rate (2016-2021)
7 Global Pirfenidone Forecast
7.1 Global Pirfenidone Revenue, Sales and Growth Rate (2021-2026)
7.2 Pirfenidone Market Forecast by Regions (2021-2026)
7.2.1 North America Pirfenidone Market Forecast (2021-2026)
7.2.2 Europe Pirfenidone Market Forecast (2021-2026)
7.2.3 China Pirfenidone Market Forecast (2021-2026)
7.2.4 Japan Pirfenidone Market Forecast (2021-2026)
7.2.5 Southeast Asia Pirfenidone Market Forecast (2021-2026)
7.2.6 Other Regions Pirfenidone Market Forecast (2021-2026)
7.3 Pirfenidone Market Forecast by Type (2021-2026)
7.3.1 Global Pirfenidone Sales Forecast by Type (2021-2026)
7.3.2 Global Pirfenidone Market Share Forecast by Type (2021-2026)
7.4 Pirfenidone Market Forecast by Application (2021-2026)
7.4.1 Global Pirfenidone Sales Forecast by Application (2021-2026)
7.4.2 Global Pirfenidone Market Share Forecast by Application (2021-2026)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Pirfenidone Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Pirfenidone Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Pirfenidone
Figure Market Concentration Ratio and Market Maturity Analysis of Pirfenidone
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Pirfenidone Market Size by Big Type
Figure Global Market Share of Pirfenidone by Big Type in 2020
Figure Tablet Picture (2016-2021)
Figure Capsule Picture (2016-2021)
Global Pirfenidone Market Size by Big Application
Table Global Pirfenidone Market Size by Application
Figure Global Pirfenidone Market Share by Big Application in 2020
Figure Mild Idiopathic Pulmonary Fibrosis Picture
Figure Moderate Idiopathic Pulmonary Fibrosis Picture
Figure Other Picture
Table Global Pirfenidone Comparison by Regions (M USD) ?2016-2026?
Figure Global Pirfenidone Market Size (Million US$) (2016-2026)
Figure North America Pirfenidone Revenue (Million US$) Growth Rate (2016-2026)
Figure Europe Pirfenidone Revenue (Million US$) Growth Rate (2016-2026)
Figure China Pirfenidone Revenue (Million US$) Growth Rate (2016-2026)
Figure Japan Pirfenidone Revenue (Million US$) Growth Rate (2016-2026)
Figure Southeast Asia Pirfenidone Revenue (Million US$) Growth Rate (2016-2026)
Table Business Impact Assessment - Covid-19
Table Market Trends and Pirfenidone Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Pirfenidone Sales by Manufacturer (2016-2021)
Figure Global Pirfenidone Sales Market Share by Manufacturer in 2020
Table Global Pirfenidone Revenue by Manufacturer (2016-2021)
Figure Global Pirfenidone Revenue Market Share by Manufacturer in 2020
Table Global Pirfenidone Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Pirfenidone Manufacturer (Revenue) Market Share in 2020
Figure Top 10 Pirfenidone Manufacturer (Revenue) Market Share in 2020
Table Date of Key Manufacturers Enter into Pirfenidone Market
Table Key Manufacturers Pirfenidone Product Type
Table Mergers & Acquisitions Planning
Table Genentech (Roche) Company Profile
Table Pirfenidone Product Introduction, Application and Specification of Genentech (Roche)
Table Pirfenidone Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2016-2021
Table Company One Main Business
Table Company One Recent Development
Table Shionogi Company Profile
Table Pirfenidone Product Introduction, Application and Specification of Shionogi
Table Pirfenidone Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Shionogi Recent Development
Table GNI Group Company Profile
Table Pirfenidone Product Introduction, Application and Specification of GNI Group
Table Pirfenidone Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table GNI Group Main Business
Table GNI Group Recent Development
Table Beijing Continent Company Profile
Table Pirfenidone Product Introduction, Application and Specification of Beijing Continent
Table Pirfenidone Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Beijing Continent Main Business
Table Beijing Continent Recent Development
Table Beijing Continent Main Business
Table Beijing Continent Recent Development
Table Cipla Company Profile
Table Pirfenidone Product Introduction, Application and Specification of Cipla
Table Pirfenidone Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Cipla Main Business
Table Cipla Recent Development
Table Lupin Ltd Company Profile
Table Pirfenidone Product Introduction, Application and Specification of Lupin Ltd
Table Pirfenidone Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Lupin Ltd Main Business
Table Lupin Ltd Recent Development
Table Zydus Cadila Company Profile
Table Pirfenidone Product Introduction, Application and Specification of Zydus Cadila
Table Pirfenidone Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Zydus Cadila Main Business
Table Zydus Cadila Recent Development
Table Glenmark Pharmaceuticals Company Profile
Table Pirfenidone Product Introduction, Application and Specification of Glenmark Pharmaceuticals
Table Pirfenidone Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Glenmark Pharmaceuticals Main Business
Table Glenmark Pharmaceuticals Recent Development
Table Koye Pharmaceuticals Company Profile
Table Pirfenidone Product Introduction, Application and Specification of Koye Pharmaceuticals
Table Pirfenidone Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Koye Pharmaceuticals Main Business
Table Koye Pharmaceuticals Recent Development
Table MSN Laboratories Company Profile
Table Pirfenidone Product Introduction, Application and Specification of MSN Laboratories
Table Pirfenidone Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table MSN Laboratories Main Business
Table MSN Laboratories Recent Development
Table Wockhardt Company Profile
Table Pirfenidone Product Introduction, Application and Specification of Wockhardt
Table Pirfenidone Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Wockhardt Main Business
Table Wockhardt Recent Development
Table Incepta Pharmaceuticals Company Profile
Table Pirfenidone Product Introduction, Application and Specification of Incepta Pharmaceuticals
Table Pirfenidone Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Incepta Pharmaceuticals Main Business
Table Incepta Pharmaceuticals Recent Development
Table Unimed Unihealth Company Profile
Table Pirfenidone Product Introduction, Application and Specification of Unimed Unihealth
Table Pirfenidone Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Unimed Unihealth Main Business
Table Unimed Unihealth Recent Development
Figure Global Pirfenidone Sales and Growth Rate (2016-2021)
Figure Global Pirfenidone Revenue and Growth Rate (2016-2021)
Table Global Pirfenidone Sales by Regions (2016-2021)
Figure Global Pirfenidone Sales Market Share by Regions in 2020
Table Global Pirfenidone Revenue by Regions (2016-2021)
Figure Global Pirfenidone Revenue Market Share by Regions in 2020
Figure North America Pirfenidone Sales and Growth Rate (2016-2021)
Figure Europe Pirfenidone Sales and Growth Rate (2016-2021)
Figure China Pirfenidone Sales and Growth Rate (2016-2021)
Figure Japan Pirfenidone Sales and Growth Rate (2016-2021)
Figure Southeast Asia Pirfenidone Sales and Growth Rate (2016-2021)
Figure Other Regions Pirfenidone Sales and Growth Rate (2016-2021)
Table Global Pirfenidone Sales by Big Type (2016-2021)
Table Global Pirfenidone Sales Market Share by Big Type (2016-2021)
Figure Global Pirfenidone Sales Market Share by Big Type in 2019
Table Global Pirfenidone Revenue by Big Type (2016-2021)
Table Global Pirfenidone Revenue Market Share by Big Type (2016-2021)
Table Global Pirfenidone Revenue Market Share by Big Type in 2019
Figure Global Tablet Sales Growth Rate (2016-2021)
Figure Global Tablet Price (2016-2021)
Figure Global Capsule Sales Growth Rate (2016-2021)
Figure Global Capsule Price (2016-2021)
Figure Global Other Sales Growth Rate (2016-2021)
Table Global Pirfenidone Sales by Big Application (2016-2021)
Table Global Pirfenidone Sales Market Share by Big Application (2016-2021)
Figure Global Pirfenidone Sales Market Share by Big Application in 2019
Figure Global Mild Idiopathic Pulmonary Fibrosis Sales Growth Rate (2016-2021)
Figure Global Moderate Idiopathic Pulmonary Fibrosis Sales Growth Rate (2016-2021)
Figure Global Other Sales Growth Rate (2016-2021)
Figure Global Pirfenidone Sales and Growth Rate (2021-2026)
Figure Global Pirfenidone Revenue and Growth Rate (2021-2026)
Table Global Pirfenidone Sales Forecast by Regions (2021-2026)
Table Global Pirfenidone Market Share Forecast by Regions (2021-2026)
Figure North America Sales Pirfenidone Market Forecast (2021-2026)
Figure Europe Sales Pirfenidone Market Forecast (2021-2026)
Figure China Sales Pirfenidone Market Forecast (2021-2026)
Figure Japan Sales Pirfenidone Market Forecast (2021-2026)
Figure Southeast Asia Sales Pirfenidone Market Forecast (2021-2026)
Figure Other Regions Sales Pirfenidone Market Forecast (2021-2026)
Table Global Pirfenidone Sales Forecast by Type (2021-2026)
Table Global Pirfenidone Market Share Forecast by Type (2021-2026)
Table Global Pirfenidone Sales Forecast by Application (2021-2026)
Table Global Pirfenidone Market Share Forecast by Application (2021-2026)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pirfenidone
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Pirfenidone Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America Pirfenidone Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe Pirfenidone Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe Pirfenidone Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan Pirfenidone Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan Pirfenidone Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China Pirfenidone Production (K Units) Growth Rate Forecast (2020-2025)
Figure China Pirfenidone Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Genentech (Roche)
Shionogi
GNI Group
Beijing Continent
Cipla
Lupin Ltd
Zydus Cadila
Glenmark Pharmaceuticals
Koye Pharmaceuticals
MSN Laboratories
Wockhardt
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)